SEC Form 4 · accession 0001645627-17-000146
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Dec 7, 2017
Accepted (ET)
Dec 12, 2017 · 7:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 7, 2017 | P | 3,000 | $0.0577 | A | 24,442,189 | D | |
| Common Stock | Dec 7, 2017 | P | 5,000 | $0.0576 | A | 24,447,189 | D | |
| Common Stock | Dec 7, 2017 | P | 5,000 | $0.0585 | A | 24,452,189 | D | |
| Common Stock | Dec 7, 2017 | P | 3,000 | $0.0595 | A | 24,455,189 | D | |
| Common Stock | Dec 7, 2017 | P | 5,000 | $0.0595 | A | 24,460,189 | D |
Table II — derivative securities
No Table II lines on this filing.